I am a person living with Brittle Type 1 Diabetes, a condition that requires constant monitoring and management. Like many others with Type 1 Diabetes, I've been eagerly hoping for a cure, a hope that's been fueled by promising developments in recent clinical trials. It is heartbreaking to realize that such advancements are within our reach, yet unattainable due to bureaucratic language preventing access.

The Islet Act is a crucial piece of legislation that could change the lives of thousands of people like me. Unfortunately, the wording of the Act classifies islet cells as a drug rather than an organ, leading to significant barriers in accessing essential transplants. This classification prevents insurance companies from covering islet cell transplants, leaving many individuals unable to afford these life-changing procedures.

Changing the wording from "drug" to "organ" in the Islet Act would mean that islet cell transplants are covered by health insurance, making this groundbreaking procedure available to those who need it most. In clinical trials, islet cell transplants have demonstrated the potential to restore insulin independence in diabetic patients, dramatically improving their quality of life and reducing long-term health complications associated with diabetes.

According to recent studies, islet cell transplants have shown success rates of significant improvement in about 70% of participants, offering a safer and more effective treatment option than current diabetes management methods. The current regulatory language presents an unnecessary hurdle in providing what could be a cure for Type 1 Diabetes, thereby prolonging the suffering of countless individuals who might otherwise benefit from these advancements.

We urge lawmakers, especially Robert F. Kennedy, Jr. to revise the Islet Act and redefine islet cells as organs. This change will adhere with the latest scientific understanding and practices, while aligning the legislation with medical classifications used in other organ transplant procedures. 

Our health, longevity, and quality of life shouldn't be dictated by outdated legislative wording. By changing the classification of islet cells, we are not just solving an insurance issue; we are stepping closer to a future where Type 1 Diabetes is no longer a life sentence.

Please sign this petition to support revising the Islet Act so that more people can access and afford islet cell transplants. Together, we can make a substantial difference in the lives of those living with Type 1 Diabetes.